GlobeImmune Hep B Drug Fails Mid-Stage Study, Shares Plunge
Permalink

GlobeImmune Hep B Drug Fails Mid-Stage Study, Shares Plunge

  (Reuters) – Drug developer GlobeImmune Inc said its experimental hepatitis B drug did not…

Continue Reading →